Executive Director, Project Management
Stefan Comhaire, Executive Director, Project Management at Worldwide Clinical Trials has 24 years of experience in the pharmaceutical industry with 20 years at the Director, Executive Director or VP level. He joined Worldwide in June 2021. As Franchise Area Lead for nephrology, he oversees the renal and rare renal study portfolio at Worldwide Clinical Trials.
Submit an RFP. Ask a Question
Mr. Comhaire began his career in the pharmaceutical industry as a Clinical Research Associate (CRA) and Project Manager, overseeing infectious disease studies at a European-based mid-size CRO. Following his migration to the U.S., he assumed the responsibilities of Director of Clinical Operations and VP of Clinical Research, managing the U.S. division of the company as well as providing executive oversight to all studies executed by the US entity. More recently, he has guided a small pharma company through its Phase III clinical development, and prior to joining Worldwide, served as Executive Director for a CRO focused on early phase clinical development.
Throughout his career, Mr. Comhaire has participated in various clinical development, trial design, and advisory committees. In addition, he has managed and overseen more than 100 phase I-III clinical trials across various therapeutic areas, including infectious diseases, nephrology, CNS, inflammatory, genetic and GI disorders, as well as endocrinology, respiratory, women’s health, and orthopedics.
Mr. Comhaire has conducted studies with neonates, children, adolescents, adults, and the elderly, and has experience with renal and hepatic impairment PK studies, gene therapy and gene editing trials. His rare disease experience includes adenosine deaminase deficiency, autosomal polycystic kidney disease, C3 glomerulonephritis, cystic fibrosis, Fabry disease, IgA nephropathy, lamellar ichthyosis, Lesch–Nyhan syndrome, lupus nephritis, membranoproliferative glomerulonephritis, Niemann–Pick disease, and primary hyperoxaluria.
Mr. Comhaire has an M.S. degree in Biology from the University of Antwerp, Belgium, and is a member of the American Society of Nephrology (ASN) and the International Society for Glomerular Diseases (ISGD).